As expected, CB2 agonist treatment markedly increased the levels of p-Akt(Ser473), p-Erk(Thr202/Tyr204), and p-Stat3 (Tyr705) in AD-MSCs subjected to H2O2/SD(P < 0.05). This evidence concerns the gene CNR2 and Alzheimer disease.